During an interactive session at Becker's Payer Issues Roundtable, leaders from WNS — Asheesh Tiwari, Corporate Vice President, Markets & Growth for Healthcare and Life sciences and Anand Jha, Corporate Vice President, Digital Transformation, Healthcare and Life Sciences and supported…
The Latest
Kansas Gov. Laura Kelly has tried unsuccessfully for years to expand Medicaid in the state and now has a new "middle of the road" plan that includes work requirements, NPR affiliate KCUR reported Dec. 18.
Several payers named new top leaders in 2023. Notable transitions include Envision Healthcare CEO Jim Rechtin's appointment as Humana's next CEO and former Aetna CEO Mark Bertolini's appointment as CEO of Oscar Health.
In 2023, these eight Blue Cross Blue Shield leaders shared with Becker's about the latest initiatives at their companies and their thoughts on some of the most pressing issues in healthcare today.
From several clinical executives to those at the helm of subsidiaries, 10 Elevance Health leaders sat down with Becker's in 2023 to share about the company's latest initiatives and its response to wider healthcare trends.
The Justice Department wants Humana's lawsuit challenging a CMS rule that would implement stricter auditing standards on Medicare Advantage plans moved to a different court, then thrown out.
Some of the nation's largest health insurers employ or employed physicians who have a history of malpractice or have been reprimanded by state medical boards, according to a Dec. 15 report from ProPublica and The Capitol Forum.
Humana is the latest insurer facing a lawsuit over allegedly using automated tools to deny Medicare Advantage members' claims, and Molina expects its acquisition of Bright Health's Medicare Advantage business to close soon.
HHS is urging states to do more to prevent eligible children from being disenrolled from Medicaid coverage.
North Carolina, Connecticut and Delaware's employee health plans are all grappling with how to cover the high cost of weight loss drugs, with each implementing limitations around coverage of the expensive medications.